Regulatory News: Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a robotic platform for ...
LYON, France, January 29, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the University of Miami Sylvester Comprehensive ...
To see Spark’s full report on EDAP stock, click here.
Sonire Therapeutics, a U.S.-based clinical-stage medical device company, today announced the completion of patient enrollment in SUNRISE-I, a randomized controlled trial evaluating the safety and ...
Key Points Interested in Edap Tms S.A.? Here are five stocks we like better. Edap Tms is rebranding as FocalTherics and ...
The first ultrasound system for the ablation of prostate tissue in the United States has just been approved by the Food and Drug Administration (FDA). The Sonablate 450, developed by SonaCare Medical, ...
LYON, France, September 28, 2021-- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that University of Washington Medicine has acquired ...
TOKYO, Oct. 16, 2024 /PRNewswire/ -- SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, Japan, announces that its self-developed next-generation HIFU (High-Intensity ...
A US Food and Drug Administration (FDA) advisory committee voted October 1 not to recommend approval, at least for now, of a high-intensity focused ultrasound (HIFU) device to treat some patients with ...
Men hoping to avoid some of the dreaded side effects of prostate cancer treatment are shelling out tens of thousands of dollars for a new procedure whose long-term effects are unknown, even though ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results